Anna Sureda – Therapy of lymphomas, what’s new at EHA 2021 By Amnon Ron|2021-07-10T07:23:40+00:00July 10th, 2021|All, EHA 2021|Comments Off on Anna Sureda – Therapy of lymphomas, what’s new at EHA 2021 Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkEmail About the Author: Amnon Ron Related Posts Prof. He Huang – Non-viral, specifically targeted CAR-T cells, achieve high safety and efficacy in B-NHL Prof. He Huang – Non-viral, specifically targeted CAR-T cells, achieve high safety and efficacy in B-NHL Prof. Mikkael Sekeres – Azacitidine plus venetoclax for myelodysplastic syndromes Prof. Mikkael Sekeres – Azacitidine plus venetoclax for myelodysplastic syndromes Dr. Adi Nagler – Single cell sequencing to chronic lymphocytic leukemia Dr. Adi Nagler – Single cell sequencing to chronic lymphocytic leukemia Prof. Meral Beksac – The recent developments in the field of bispecific T-cell engagers Prof. Meral Beksac – The recent developments in the field of bispecific T-cell engagers Prof. Selim Corbacioglu – The importance of veno-occlusive disease prophylaxis Prof. Selim Corbacioglu – The importance of veno-occlusive disease prophylaxis
